Theravance Biopharma (TBPH) Current Taxes (2014 - 2026)
Theravance Biopharma (TBPH) posted quarterly Current Taxes of $5.3 million for Q1 2026, down 9.67% year-over-year from $5.9 million in Q1 2025, and little changed quarter-over-quarter from $5.3 million in Q4 2025.
Theravance Biopharma (TBPH) Current Taxes (2014 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has reported Current Taxes for 4 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Taxes fell 9.67% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (down 9.67% YoY), while the FY2025 annual figure was $5.3 million, down 9.67% from the prior year.
- Current Taxes held at $5.3 million in Q1 2026 per TBPH's latest filing, from $5.3 million in the prior quarter.
- Across five years, Current Taxes topped out at $26.7 million in Q2 2025 and bottomed at $4.1 million in Q3 2025.
- Historically, Current Taxes has averaged $8.8 million across 3 years, with a median of $5.6 million in 2024.
- On a YoY basis, Current Taxes climbed as much as 9.67% in 2025 and fell as far as 9.67% in 2025.
- Theravance Biopharma's Current Taxes stood at $5.9 million in 2024, then fell by 9.67% to $5.3 million in 2025, then changed by 0.0% to $5.3 million in 2026.
- Business Quant data shows TBPH's Current Taxes at $5.3 million in Q1 2026, $5.3 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.29 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 26.70 Mn |
| Mar 31, 2025 | 5.85 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2014 | 5.22 Mn |